XML 48 R14.htm IDEA: XBRL DOCUMENT v3.25.1
Equity Incentive Plan
12 Months Ended
Dec. 31, 2024
Equity Incentive Plan  
Equity Incentive Plan

8. Equity Incentive Plan

In September 2019, the Company’s Board of Directors approved the 2019 Equity Incentive Plan (the “2019 Plan) and each outstanding option to purchase Aprea AB ordinary shares pursuant to a previous plan was cancelled and the Company issued to each holder of such Aprea AB option, a substitute option to purchase, on the same terms and conditions as were applicable to such Aprea AB option, shares of the Company’s common stock pursuant to the 2019 Plan.

The Board of Directors has the discretion to provide for accelerated vesting under the 2019 Plan. At December 31, 2024, there were 75,589 shares available for future grant under the 2019 Plan.

The Company recorded stock-based compensation expense of $0.5 million and $0.4 million during the years ended December 31, 2024 and 2023, respectively. As of December 31, 2024, there was $0.8 million of unrecognized compensation cost related to nonvested share-based compensation arrangements granted under the 2019 Plan, which is expected to be recognized over a weighted-average period of approximately 2.6 years.

The fair value of each option award is estimated on the date of grant using Black-Scholes, with the assumptions noted in the table below. Expected volatility for the Company’s common stock was determined based on an average of the historical volatility of a peer group of similar public companies. The expected term of options granted to employees was calculated using the simplified method, which represents the average of the contractual term of the option and the weighted-average vesting period of the option. The Company uses the simplified method because it does not have sufficient historical option exercise data to provide a reasonable basis upon which to estimate expected term. The contractual life of the option was used for the expected life of options granted to non-employee. The assumed dividend yield is based upon the Company’s expectation of not paying dividends in the foreseeable future. The risk-free rate for periods within the expected life of the option is based upon the implied yield on a U.S. Treasury security in effect at the time of grant.

The assumptions used in Black-Scholes are as follows:

Year ended December 31,

    

2024

    

2023

Expected volatility

 

83.8%-92.3%

 

84.8%-91.6%

Risk‑free rate

 

4.18%-4.64%

3.41%-4.73%

Expected dividend yield

 

0%

  

0%

Expected term in years

 

5.50 - 10.00

 

5.50 - 10.00

A summary of option activity under the Plan during the years ended December 31, 2024 and 2023 are as follows:

    

    

    

Weighted

    

Weighted

    

    

average

average

exercise

remaining

Aggregate

Number of

price per

contractual

intrinsic

options

share

term (in years)

value

Outstanding at December 31, 2022

480,274

$

89.49

 

6.8

$

Granted

 

 

123,062

 

5.68

 

  

 

  

Cancelled/Forfeited

 

 

(6,870)

 

21.80

 

  

 

  

Outstanding at December 31, 2023

596,466

$

72.95

 

6.2

$

45,825

Granted

 

 

147,340

 

5.79

 

  

 

  

Cancelled/Forfeited

 

 

(28,186)

 

5.36

 

  

 

  

Outstanding at December 31, 2024

715,620

$

61.79

 

6.1

$

Exercisable at December 31, 2024

516,242

$

83.26

 

5.0

$

Vested or expected to vest at December 31, 2024

715,620

$

61.79

 

6.1

$

The weighted-average grant date fair value of options granted during the years ended December 31, 2024 and 2023, was $4.53 and $4.35, per share, respectively.

Restricted Stock Units

During the year ended December 31, 2024, the Company granted the following RSU’s:

a total of 16,820 RSUs to executive officers of the Company which vest ratably on the 1st, 2nd and 3rd anniversaries of the grant date, 6,730 of which were canceled prior to vesting.
a total of 6,270 RSUs to non-employee directors of the Company which vest on the one-year anniversary of the grant date.

During the year ended December 31, 2023, the Company granted the following RSU’s:

a total of 17,493 RSUs to executive officers of the Company which vest ratably on the 1st, 2nd and 3rd anniversaries of the grant date.
a total of 3,000 RSUs to non-employee directors of the Company which vest on the one-year anniversary of the grant date.

As of December 31, 2024, there was $0.2 million of unrecognized compensation cost related to RSUs granted under the 2019 Plan, which is expected to be recognized over a weighted-average period of approximately 1.9 years.

The following table shows restricted stock unit activity during the year ended December 31, 2024:

Weighted

average

grant date

Shares

fair value

Outstanding at December 31, 2022

12,734

$

21.80

Granted

20,493

8.81

Vested

(5,102)

21.80

Cancelled/Forfeited

(4,255)

21.80

Outstanding at December 31, 2023

23,870

$

10.00

Granted

23,090

5.56

Vested

(10,518)

5.08

Cancelled/Forfeited

(6,730)

5.25

Outstanding at December 31, 2024

29,712

$

7.83